The article discusses the introduction of factors Oct4, Sox2, c-Myc and Klf4 into fibroblasts to endow them with some of the pluripotent characteristics of embryonic stem cells. Factors selected should not only induce pluripotency, but could also switch on the resistance gene to produce pluripotent cells selectable by their ability to grow in the presence of a drug.